SequelSEC

Sotera Health Co SHC

Services-Misc Health & Allied Services, NEC · CIK 0001822479 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$321.38M
Fiscal year ended 2026-06-30
Operating income
Unavailable
Fiscal year ended 2026-06-30
Free cash flow
$42.05M
Fiscal year ended 2026-06-30

Sotera Health Co (SHC) reported revenue of $321.38M and net income of $53.64M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Sotera Health Co’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Misc Health & Allied Services, NEC.

Income

Sotera Health Co income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$321.38M$280.04M$303.44M$311.31M$294.34M$254.52M$290.20M$285.47M$276.59M$248.18M
Cost of revenue$143.41M$132.98M$137.52M$133.75M$127.72M$119.09M$125.84M$127.44M$123.80M$121.06M
Gross profit$177.96M$147.07M$165.92M$177.56M$166.62M$135.43M$164.36M$158.02M$152.79M$127.12M
Operating incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$87.15M$80.51M$76.80M$53.17M
Net income$53.64M$26.59M$34.85M$48.40M$7.96M-$13.26M$12.32M$17.00M$8.75MUnavailable
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 288.15Mshares 287.62MUnavailableshares 286.74Mshares 285.76Mshares 283.56MUnavailableshares 285.56Mshares 284.54Mshares 284.06M
Pretax income$78.05M$42.61M$70.50M$72.94M$18.90M-$14.82M$44.96M$42.75M$15.14M$11.01M
Income tax expense$24.41M$16.02M$35.65M$24.54M$10.94M-$1.56M$32.64M$25.76M$6.39M$4.69M
Diluted EPS$0.19$0.09$0.12$0.17$0.03$-0.05$0.05$0.06$0.03$0.02
Selling, general & administrative$68.16M$68.21M$57.51M$63.29M$68.89M$63.06M$61.84M$62.01M$60.58M$58.21M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Sotera Health Co balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$356.72M$314.15M$344.62M$299.19M$332.44M$304.39M$277.24M$306.74M$246.08M$261.13M
Total assets$3.31B$3.24B$3.26B$3.19B$3.22B$3.10B$3.07B$3.15B$3.06B$3.06B
Current assets$646.46M$585.97M$613.41M$577.82M$608.18M$554.99M$526.04M$563.61M$497.68M$487.18M
Total liabilities$2.64B$2.61B$2.66B$2.64B$2.71B$2.68B$2.67B$2.68B$2.64B$2.63B
Current liabilities$231.24M$207.80M$249.58M$242.40M$246.32M$225.99M$191.00M$195.54M$169.63M$152.34M
Total equity incl. NCI$665.65M$622.50M$606.04M$550.47M$511.28M$414.09M$404.91M$470.16M$422.76M$429.39M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$56.37M$57.49M$54.38M$49.86M$59.95M$61.04M$49.16M$53.65M$57.87M$51.34M
Accounts receivable$150.54M$137.26M$139.33M$142.39M$136.56M$128.07M$140.33M$130.12M$123.66M$111.07M
Goodwill$1.09B$1.10B$1.10B$1.10B$1.10B$1.08B$1.08B$1.10B$1.10B$1.10B
Long-term debt$2.13B$2.12B$2.13B$2.13B$2.20B$2.21B$2.21B$2.21B$2.21B$2.22B
Accounts payable$101.02M$76.69M$77.96M$61.39M$63.66M$70.11M$55.10M$70.75M$64.49M$61.58M

Cash flow

Sotera Health Co cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow$88.50M$29.44M$103.10M$71.15M$57.42M$55.52M$55.72M$97.45M$61.30M$9.70M
Capital expenditures$46.45M$46.17M$50.70M$36.17M$31.23M$19.92M$65.87M$36.39M$41.92M$34.89M
Investing cash flow-$43.30M-$45.13M-$50.70M-$33.34M-$31.23M-$19.88M-$65.87M-$36.35M-$41.92M-$34.85M
Financing cash flow-$2.40M-$12.78M-$8.18M-$77.34M-$6.93M-$8.09M-$6.55M-$2.65M-$29.42M-$11.94M
Net change in cash$40.78M-$30.51M$45.43M-$33.25M$28.19M$27.22M-$29.62M$60.72M-$15.06M-$38.83M
Stock-based compensation$7.22M$14.39M$7.57M$7.95M$8.12M$7.24M$8.14M$9.79M$10.18M$8.66M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Sotera Health Co derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow$42.05M-$16.73M$52.40M$34.98M$26.19M$35.60M-$10.15M$61.06M$19.37M-$25.19M
Gross margin55.4%52.5%54.7%57.0%56.6%53.2%56.6%55.4%55.2%51.2%
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF margin13.1%-6.0%17.3%11.2%8.9%14.0%-3.5%21.4%7.0%-10.2%
SBC / revenue2.2%5.1%2.5%2.6%2.8%2.8%2.8%3.4%3.7%3.5%
Current ratio2.80x2.82x2.46x2.38x2.47x2.46x2.75x2.88x2.93x3.20x
Revenue YoY growth9.2%10.0%4.6%9.1%6.4%2.6%-6.5%8.5%8.3%12.5%
Net margin16.7%9.5%11.5%15.5%2.7%-5.2%4.2%6.0%3.2%Unavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue14.5%16.5%16.7%11.6%10.6%7.8%22.7%12.7%15.2%14.1%
Long-term debt / equity3.19xUnavailable3.51x3.87xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate31.3%37.6%50.6%33.6%57.9%Unavailable72.6%60.2%42.2%42.6%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-01View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.